Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ladanyi

Showing results (71-80 of 569) with videos related to

Pageof 57
Sort By:
The American Journal of Surgical Pathology|May 27, 2003
Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assayPedram Argani, Priti Lal, Brian Hutchinson, et al.
Cancer Research|January 25, 2003
The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomasCynthia Laflamme, Christine Filion, Julia A Bridge, et al.
Seminars in Cancer Biology|July 31, 2020
Precision medicine in non-small cell lung cancer: Current applications and future directionsSoo-Ryum Yang, Anne M Schultheis, Helena Yu, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusionsLu Wang, Rohit Bhargava, Tao Zheng, et al.
Human Pathology|July 3, 2002
Expression of SSX genes in the neoplastic cells of Hodgkin's lymphomaGisele W B Colleoni, Paola Capodieci, Satish Tickoo, et al.
Nature Reviews. Cancer|July 15, 2011
Advances in sarcoma genomics and new therapeutic targetsBarry S Taylor, Jordi Barretina, Robert G Maki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2011
New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancerGeoffrey R Oxnard, Maria E Arcila, Juliann Chmielecki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profilesNatasha Rekhtman, Laetitia Borsu, Boris Reva, et al.
Acta Cytologica|December 14, 2011
BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosisAgnes Colanta, Oscar Lin, Laura Tafe, et al.
Sarcoma|February 23, 2013
Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literatureAlison O'Neill, Nilay Shah, Naamah Zitomersky, et al.
Pageof 57

Showing results (71-80 of 569) with videos related to

Sort By:
Pageof 57
The American Journal of Surgical Pathology|May 27, 2003
Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assayPedram Argani, Priti Lal, Brian Hutchinson, et al.
Cancer Research|January 25, 2003
The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomasCynthia Laflamme, Christine Filion, Julia A Bridge, et al.
Seminars in Cancer Biology|July 31, 2020
Precision medicine in non-small cell lung cancer: Current applications and future directionsSoo-Ryum Yang, Anne M Schultheis, Helena Yu, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusionsLu Wang, Rohit Bhargava, Tao Zheng, et al.
Human Pathology|July 3, 2002
Expression of SSX genes in the neoplastic cells of Hodgkin's lymphomaGisele W B Colleoni, Paola Capodieci, Satish Tickoo, et al.
Nature Reviews. Cancer|July 15, 2011
Advances in sarcoma genomics and new therapeutic targetsBarry S Taylor, Jordi Barretina, Robert G Maki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2011
New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancerGeoffrey R Oxnard, Maria E Arcila, Juliann Chmielecki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profilesNatasha Rekhtman, Laetitia Borsu, Boris Reva, et al.
Acta Cytologica|December 14, 2011
BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosisAgnes Colanta, Oscar Lin, Laura Tafe, et al.
Sarcoma|February 23, 2013
Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literatureAlison O'Neill, Nilay Shah, Naamah Zitomersky, et al.
Pageof 57